Avantor® Opens New Bridgewater Innovation Center Focused on Solving Life Science's Biggest Challenges
Avantor (NYSE: AVTR) announced the opening of its new flagship Bridgewater Innovation Center in New Jersey. The 60,000-square-foot facility doubles the previous laboratory and pilot plant capacity, featuring dedicated spaces for upstream and downstream process development, analytical testing labs, and a viral vector laboratory. The center, part of Avantor's global network of 13 research facilities, is staffed with Ph.D. scientists, bioengineers, and process engineers to support biomanufacturing optimization and accelerate development of therapies including monoclonal antibodies, cell and gene therapy, and mRNA workflows.
Avantor (NYSE: AVTR) ha annunciato l'apertura della sua nuova sede principale, il Bridgewater Innovation Center, nel New Jersey. La struttura di 60.000 piedi quadrati raddoppia la capacità precedente dei laboratori e dell'impianto pilota, offrendo spazi dedicati per lo sviluppo dei processi a monte e a valle, laboratori di analisi e un laboratorio per vettori virali. Il centro, parte della rete globale di Avantor composta da 13 strutture di ricerca, è composto da scienziati con dottorato, bioingegneri e ingegneri di processo per supportare l'ottimizzazione della biomanifattura e accelerare lo sviluppo di terapie come anticorpi monoclonali, terapia cellulare e genica e flussi di lavoro mRNA.
Avantor (NYSE: AVTR) anunció la apertura de su nuevo centro insignia, el Bridgewater Innovation Center, en Nueva Jersey. La instalación de 60,000 pies cuadrados duplica la capacidad anterior del laboratorio y la planta piloto, con espacios dedicados para el desarrollo de procesos upstream y downstream, laboratorios de pruebas analíticas y un laboratorio de vectores virales. El centro, parte de la red global de Avantor con 13 instalaciones de investigación, cuenta con un equipo de científicos con doctorado, bioingenieros e ingenieros de procesos para apoyar la optimización de la biomanufactura y acelerar el desarrollo de terapias que incluyen anticuerpos monoclonales, terapia celular y génica, y flujos de trabajo de ARNm.
Avantor (NYSE: AVTR)는 뉴저지에 새로운 플래그십 브릿지워터 혁신 센터의 개소를 발표했습니다. 60,000 제곱피트 규모의 시설은 이전의 실험실 및 파일럿 플랜트 용량을 두 배로 늘리며, 상류 및 하류 프로세스 개발, 분석 테스트 실험실, 바이러스 벡터 실험실을 위한 전용 공간을 특징으로 합니다. 이 센터는 Avantor의 13개 연구 시설로 구성된 글로벌 네트워크의 일환으로, 생물 제조 최적화를 지원하고 단클론 항체, 세포 및 유전자 치료, mRNA 작업 흐름을 포함한 치료제 개발을 가속화하기 위해 박사급 과학자, 생물공학자 및 프로세스 엔지니어로 구성된 인력을 갖추고 있습니다.
Avantor (NYSE: AVTR) a annoncé l'ouverture de son nouveau centre phare, le Bridgewater Innovation Center, dans le New Jersey. Cette installation de 60 000 pieds carrés double la capacité précédente des laboratoires et de l'usine pilote, avec des espaces dédiés au développement des procédés amont et aval, des laboratoires d'analyse et un laboratoire de vecteurs viraux. Le centre, qui fait partie du réseau mondial d'Avantor composé de 13 établissements de recherche, est composé de scientifiques titulaires d'un doctorat, de bioingénieurs et d'ingénieurs de processus pour soutenir l'optimisation de la biomanufacturation et accélérer le développement de thérapies telles que des anticorps monoclonaux, des thérapies cellulaires et géniques, et des flux de travail ARNm.
Avantor (NYSE: AVTR) hat die Eröffnung seines neuen Flaggschiffes, des Bridgewater Innovation Centers, in New Jersey angekündigt. Die 60.000 Quadratfuß große Einrichtung verdoppelt die frühere Kapazität der Labore und Pilotanlagen und bietet spezielle Bereiche für die Entwicklung von Prozessen der Aufwärts- und Abwärtsintegration, analytische Testlabore und ein Labor für virale Vektoren. Das Zentrum, Teil von Avantors globalem Netzwerk von 13 Forschungseinrichtungen, wird von promovierten Wissenschaftlern, Bioingenieuren und Verfahrensingenieuren besetzt, um die Bioproduktion zu optimieren und die Entwicklung von Therapien wie monoklonalen Antikörpern, Zell- und Gentherapie sowie mRNA-Workflows zu beschleunigen.
- Doubled laboratory and pilot plant capacity with new 60,000-square-foot facility
- Enhanced capabilities for monoclonal antibodies, cell and gene therapy, and mRNA workflows
- Expanded research infrastructure supporting faster problem-solving and process optimization
- None.
Insights
The opening of Avantor's new 60,000 square foot Bridgewater Innovation Center represents a strategic expansion that doubles their R&D capacity, but its immediate financial impact remains While this facility enhances Avantor's capabilities in high-growth areas like monoclonal antibodies, cell and gene therapy and mRNA workflows, the return on investment will materialize gradually over the medium to long term.
The expansion aligns with increasing demand in the biopharma sector, particularly in advanced therapy development. The facility's focus on process optimization and scale-up capabilities could lead to improved operational efficiencies and stronger customer relationships. However, the significant fixed costs associated with such facilities typically mean a multi-year pathway to profitability.
Avantor's new Bridgewater Innovation Center spans 60,000 square feet, doubling its previous laboratory and pilot plant capacity. Purpose-designed for collaborative work, the center houses spaces for upstream and downstream process development, dedicated analytical testing labs, and a viral vector laboratory. An expanded pilot plant supports scale-up simulations, enabling rapid customization across the entire bioprocessing workflow.
"Our new Bridgewater Innovation Center is twice the size of our previous facility and adds capacity, talent and capabilities to support the growing demands for monoclonal antibodies, cell and gene therapy and mRNA workflows," said Michael Stubblefield, President and CEO of Avantor. "Working side-by-side with customers in our network of innovation centers across the globe enables us to power science at every step to deliver life-changing therapies faster, and more cost effectively."
The Bridgewater Innovation Center allows Avantor to optimize and accelerate biomanufacturing processes at scale; resulting in faster problem solving, streamlined knowledge exchange, and strategic co-innovation. Staffed with Ph.D. scientists, bioengineers, biologists, and process engineers, this center enhances both capacity and expertise to support customers' needs. The facility also supports Avantor's sustainability goals, reinforcing the Company's commitment to environmental responsibility.
For more information about the Bridgewater Innovation Center, visit: https://www.avantorsciences.com/us/en/about/innovation-in-biopharma/avantor-bridgewater-innovation-center.
About Avantor
Avantor® is a leading life science tools company and global provider of mission-critical products and services to the life sciences and advanced technology industries. We work side-by-side with customers at every step of the scientific journey to enable breakthroughs in medicine, healthcare, and technology. Our portfolio is used in virtually every stage of the most important research, development and production activities at more than 300,000 customer locations in 180 countries. For more information, visit avantorsciences.com and find us on LinkedIn, X (Twitter) and Facebook.
Global Media Contact
Eric Van Zanten
Head of External Communications
Avantor
610-529-6219
Eric.VanZanten@avantorsciences.com
Investor Relations Contact
Christina Jones
Vice President, Investor Relations
Avantor
805-617-5297
Christina.Jones@avantorsciences.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/avantor-opens-new-bridgewater-innovation-center-focused-on-solving-life-sciences-biggest-challenges-302304526.html
SOURCE Avantor and Financial News
FAQ
What is the size of Avantor's new Bridgewater Innovation Center?
What types of research capabilities does Avantor's new Bridgewater facility offer?
How many innovation centers does Avantor (AVTR) operate globally?
